 |
Next-generation management of breast and gastric cancer. |
|
|
|
127-143 |
10.2122/gbc.2010.0136 |
|
Sequencing Cancer Genome and investigating biomedical systems for improving surgical oncology. |
|
|
|
144-149 |
10.2122/gbc.2010.0137 |
|
Whole-genome sequencing and epigenome analysis revolutionize biomedical sciences. |
|
|
|
150-156 |
10.2122/gbc.2010.0138 |
|
Biomarkers for personalizing health: concerns, challenges, and prospects
|
|
|
|
157-162 |
10.2122/gbc.2010.0139 |
|
KRAS-targeting agents and beyond for colorectal cancer treatment |
|
|
|
163-169 |
10.2122/gbc.2010.0140 |
|
PLX4032: A novel effective anti-melanoma drug and new ways to overcome resistance. |
|
|
|
170-174 |
10.2122/gbc.2010.0141 |
|
Personalized medicine: How and when, if ever, huge challenges could be overcome? |
|
|
|
175 - 185 |
10.2122/gbc.2010.0144 |
|
Colorectal cancer targeted treatment: advances and resistance. |
|
|
|
186 - 192 |
10.2122/gbc.2010.0142 |
|
Trastuzumab: Isolated success in the adjuvant setting and a paradigm for moving toward network oncology. |
|
|
|
193 - 198 |
10.2122/gbc.2010.0143 |
|
Totally robotic surgery for rectal cancer treatment: Advances and challenges
|
|
|
|
199-201 |
10.2122/gbc.2010.0145 |
